Mr. Rob Hill reports

EMERALD HEALTH THERAPEUTICS RECEIVES STANDARD PROCESSING LICENSE FOR VERDELITE FACILITY IN QUEBEC

Emerald Health Therapeutics Inc.'s Quebec facility, Verdelite, has received its standard processing licence from Health Canada. This licence means that, in addition to Verdelite's right to cultivate and sell cannabis flowers, it can now extract, manufacture, synthesize, test and sell next-generation cannabis products and will position Verdelite to launch these products in conjunction with the expected legalization of a broader spectrum of cannabis products in Canada in October, 2019. The licence also allows Verdelite to build and operate a laboratory for research and development of cannabis-based products.

"The ability to carry out research and development on cannabis and to extract cannabinoids and manufacture next-generation cannabis products are important steps forward for Verdelite," said Thierry Schmidt, president of Verdelite. "This processing licence will allow us to develop and offer a wide range of high-quality cannabis products, advance Verdelite and Emerald brands, and to serve recreational and medicinal consumers in Quebec and throughout Canada."

This is the third processing licence issued to Emerald by Health Canada.

About Emerald Health Therapeutics Inc.

Emerald Health is a Canadian licensed producer of cannabis. Its 50-per-cent-owned Pure Sunfarms joint venture in British Columbia is licensed to cultivate in 1.03 million square feet of the first of its two 1.1-million-square-foot greenhouses. The capacity of each greenhouse is estimated to exceed 75,000 kilograms of cannabis annually. The initial greenhouse has been scaling up production over the last four quarters and is expected to be fully planted in April.

We seek Safe Harbor.